Cargando…
Recent Advances in Cancer Immunotherapy with a Focus on FDA-Approved Vaccines and Neoantigen-Based Vaccines
Cancer immunotherapies refer to the concept of retraining the immune system to target malignant cells. Multiple immunotherapeutic options exist including immune modulating antibodies, immune stimulating cytokines, chimeric antigen receptor T cell therapy, and vaccines. Overall, this field has advanc...
Autores principales: | Hargrave, Anna, Mustafa, Abu Salim, Hanif, Asma, Tunio, Javed H., Hanif, Shumaila Nida M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10675687/ https://www.ncbi.nlm.nih.gov/pubmed/38005965 http://dx.doi.org/10.3390/vaccines11111633 |
Ejemplares similares
-
Recent Updates on mRNA Vaccines
por: Sydow, Emily, et al.
Publicado: (2022) -
Current Status of HIV-1 Vaccines
por: Hargrave, Anna, et al.
Publicado: (2021) -
Neoantigen vaccine: an emerging tumor immunotherapy
por: Peng, Miao, et al.
Publicado: (2019) -
FDA approved vaccines for monkeypox: Current eminence
por: Chopra, Hitesh, et al.
Publicado: (2022) -
New agents for the treatment of lymphoid leukemia and lymphoma: focus on recent FDA approvals
por: Stancu, Andreea Lucia, et al.
Publicado: (2014)